| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.426 | 37.523 | 62.721 | 94.246 | 75.617 | 119.415 | 162.701 | 160.472 | 291.247 | 269.665 |
| Total Income - EUR | 39.748 | 38.714 | 63.776 | 94.687 | 77.724 | 120.967 | 163.646 | 163.323 | 294.838 | 281.267 |
| Total Expenses - EUR | 13.771 | 13.001 | 10.312 | 20.866 | 12.085 | 22.256 | 6.831 | 8.309 | 21.541 | 17.280 |
| Gross Profit/Loss - EUR | 25.978 | 25.713 | 53.464 | 73.821 | 65.639 | 98.711 | 156.815 | 155.015 | 273.297 | 263.986 |
| Net Profit/Loss - EUR | 24.817 | 24.577 | 52.080 | 70.992 | 63.465 | 95.515 | 152.493 | 150.887 | 270.793 | 256.815 |
| Employees | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dionamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 953 | 491 | 414 | 1.007 | 3.172 | 9.142 | 7.031 | 5.422 | 3.996 | 2.808 |
| Current Assets | 114.476 | 43.230 | 61.330 | 90.879 | 149.141 | 118.921 | 270.620 | 259.933 | 419.203 | 650.804 |
| Inventories | 0 | 0 | 0 | 402 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 11.755 | 8 | 451 | 5.933 | 956 | 15.363 | 947 | 214.370 | 977 | 237.309 |
| Cash | 102.721 | 43.222 | 60.879 | 84.544 | 148.186 | 103.558 | 269.673 | 45.563 | 418.225 | 413.495 |
| Shareholders Funds | 107.299 | 24.622 | 52.132 | 83.487 | 134.732 | 97.123 | 247.463 | 150.936 | 301.039 | 256.863 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.131 | 19.099 | 9.612 | 8.399 | 17.582 | 30.939 | 30.188 | 114.419 | 122.160 | 396.749 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dionamed S.r.l.